CS MEDICA A/S has entered a partnership with an undisclosed fast-growing, award-winning German OTC company. This company holds a strong position in the chronic pain segment in German pharmacies and is actively seeking innovative products to expand its own-labeled CBD portfolio. The collaboration will start with the MDR-compliant medical device; the Pain Patch, with the first 10.000 (10T) units ordered--more products are likely to be added later.

The Pain Patch's launch is scheduled for third quarter-2024. Detailed information will be published on launch day. This partnership underscores CS MEDICA's strategic focus on Europe with Germany, a key market due to its size and maturity for CBD-infused products, mirroring the growing interest in the UK, Italy, and other EU markets.

With this launch, CS MEDICA extends its commitment to providing natural, science-based, and effective health solutions. Additionally, the expedited process from initial contact to a paid invoice in just nine days is testament to the company's market responsiveness and improved efficiency.